What is Jiangsu Yahong Meditech Co., Ltd.'s (688176.SS) StockRank?

MoatMap's StockRank for Jiangsu Yahong Meditech Co., Ltd. (688176.SS) is 30/100, with a Sell signal. This is a composite score combining Quality (32), Value (36), and Momentum (53) factor ranks across MoatMap's 20,000+ stock universe.

Does Jiangsu Yahong Meditech Co., Ltd. have an economic moat?

Jiangsu Yahong Meditech Co., Ltd. (688176.SS) has a Quality factor score of 32/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Jiangsu Yahong Meditech Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Jiangsu Yahong Meditech Co., Ltd. (688176.SS) is Sell, based on a StockRank of 30/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Jiangsu Yahong Meditech Co., Ltd. in?

Jiangsu Yahong Meditech Co., Ltd. (688176.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688176.SS

SELLREMOVE

Jiangsu Yahong Meditech Co., Ltd. · Healthcare · China · $961M · Avg Vol: $15M/d

StockRank

P/E (TTM)

—

ROE

-27.6%

D/E

0.2x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Jiangsu Yahong Meditech is a clinical-stage biopharmaceutical company focused on oncology. It lacks the established cash flows, high ROIC, and proven commercial-stage pricing power required by our Terry Smith and Warren Buffett lenses, making it too speculative for our concentrated book.

COMPANY DESCRIPTION

Jiangsu Yahong Meditech Co., Ltd. is a clinical-stage biopharmaceutical company focusing on the R&D of innovative drugs for genitourinary system diseases, particularly bladder and prostate cancers. Its competitive moat is built on an integrated platform for genitourinary oncology with a pipeline of late-stage, first-in-class or best-in-class drug candidates. The company is a highly specialized niche biotechnology innovator in the urological oncology sector.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	3,857	2M	30M	41M	2098.0%
EPS	-0.06	-0.10	-0.10	-0.11	—
Shares	570M	570M	570M	571M	+0.2%
Debt	3M	20M	20M	51M	164.3%
Equity	410M	353M	291M	233M	-17.1%
Op CF	-36M	-59M	-63M	-61M	—
Inv CF	-195M	-54M	118M	6M	—
Fin CF	-5M	9M	-11M	30M	—

PRICE (1M)-18.7%

SMA 50SMA 200

$1.53

RSI (14)

21.5

52W High

$2.68

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

-25.7%25.2

ROE

-27.6%26.5

GP/Assets

10.2%26.1

Op. Margin

-162.2%14.8

FCF/Assets

-15.7%21.6

Piotroski

—28.8

Int. Cover

-50.0x6.5

D/E Ratio

0.25x47.5

Current Ratio

4.07x64.0

Value

P/E (TTM)

—N/A

EV/EBITDA

-10.5x82.3

P/FCF

—N/A

P/B

3.9x30.1

P/S

20.3x17.1

Div Yield

—N/A

Momentum

52W High %

57%34.9

RS 6M

-2%75.6

SMA 50/200

1.05x72.2

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+53%54.8

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$961M

P/E (Forward)

-27.3x

Gross Margin

72.6%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688176.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
688176.SS	Jiangsu Yahong Meditech Co., Ltd.(you)	$961M	30	SELL
600252.SS	Guangxi Wuzhou Zhongheng Group Co., Ltd	$1.0B	29	SELL
002038.SZ	Beijing SL Pharmaceutical Co., Ltd.	$893M	28	SELL
603567.SS	Heilongjiang ZBD Pharmaceutical Co., Ltd.	$994M	26	SELL
300702.SZ	Zhejiang Tianyu Pharmaceutical Co., Ltd.	$989M	26	SELL
688621.SS	Beijing Sun-Novo Pharmaceutical Research Co., Ltd.	$894M	26	SELL
002940.SZ	Zhejiang AngLiKang Pharmaceutical CO.,LTD.	$1.0B	25	SELL
600422.SS	KPC Pharmaceuticals,Inc.	$999M	24	SELL
002793.SZ	Luoxin Pharmaceuticals Group Stock Co., Ltd.	$690M	31	SELL
300267.SZ	Hunan Er-Kang Pharmaceutical Co., Ltd	$1.1B	34	SELL

Peer medians: ROE 4.8% · P/E 27.8x · Gross margin 53.0%

Jiangsu Yahong Meditech Co., Ltd. (688176.SS) — Stock Score Summary

Jiangsu Yahong Meditech Co., Ltd. (688176.SS) has a MoatMap StockRank of 30/100 based on Quality (32/100), Value (36/100), and Momentum (53/100) factor scores. The current signal is SELL. Jiangsu Yahong Meditech is a clinical-stage biopharmaceutical company focused on oncology. It lacks the established cash flows, high ROIC, and proven commercial-stage pricing power required by our Terry Smith and Warren Buffett lenses, making it too speculative for our concentrated book.

Key Financial Metrics

Price	$1.53
Market Cap	$961M
P/E (Forward)	-27.25
Price/Book	3.92
Return on Equity	-27.6%
Return on Invested Capital	-25.7%
Debt/Equity	24.62
Gross Margin	72.6%
Operating Margin	-162.2%
Revenue Growth	16.3%
Free Cash Flow	$-7M

Jiangsu Yahong Meditech Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Jiangsu Yahong Meditech Co., Ltd.’s (688176.SS) StockRank?: MoatMap’s StockRank for Jiangsu Yahong Meditech Co., Ltd. (688176.SS) is 30/100, with a Sell signal. It is a composite of Quality (32), Value (36), and Momentum (53) factor ranks across MoatMap’s 20,000+ stock universe.
Does Jiangsu Yahong Meditech Co., Ltd. have an economic moat?: Jiangsu Yahong Meditech Co., Ltd. (688176.SS) has a Quality factor score of 32/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Jiangsu Yahong Meditech Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Jiangsu Yahong Meditech Co., Ltd. (688176.SS) is Sell, based on a StockRank of 30/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Jiangsu Yahong Meditech Co., Ltd. in?: Jiangsu Yahong Meditech Co., Ltd. (688176.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).